Systems Approach to Immunity and Inflammation
Systems Approach to Immunity and Inflammation
批准号:
8893876
负责人:
Richard J Ulevitch
金额:
$632.44万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2016-08-31
关键词:
AgonistAnimalsBiological Response ModifiersBreedingCellsCodeCommunicable DiseasesCommunitiesComplexDNA SequenceDataData SetDefectDendritic CellsDisciplineDiseaseEthylnitrosoureaGenesGeneticGoalsHost DefenseHumanImmuneImmune responseImmune systemImmunityImmunologistIn VitroInduced MutationInfectionInflammationInflammatoryInfluenzaInvestmentsJointsKnowledgeLinkListeriaMethodologyMethodsMouse Pox VirusMusMutagenesisMutant Strains MiceMutateMutationNational Institute of Allergy and Infectious DiseaseNatural ImmunityOther GeneticsPathway interactionsPharmaceutical PreparationsPhenotypePlayProteinsRegulationRegulator GenesResearchResearch PersonnelRoleSalmonellaSet proteinSignal TransductionSystemSystems AnalysisSystems BiologyTechniquesTechnologyTimeVaccine DesignWorkadaptive immunitycombatcostexome sequencingforward geneticsgene discoverygenetic approachgenetic pedigreein vivoinfluenzavirusmacrophagemembermouse modelmutantnew technologynew therapeutic targetnext generation sequencingnovelnovel strategiespathogenprogramspublic health relevanceresponsescreeningsuccessweb site
中文摘要
描述(申请人提供):免疫反应是一把双刃剑;它是宿主防御的绝对必要条件,但不受调节,会导致炎症性疾病。关于适当调整这些途径的机制的一些关键问题仍然没有答案。该提案旨在揭示控制NIAID优先病原体的先天和适应性反应的关键方面的新的调控机制。这个U19提出了一种新的和完全集成的方法,我们称之为系统引导的向前遗传学的免疫学研究。在这里,我们结合了联合收割机传统的正向遗传学和系统生物学方法,保留了每种策略的优势,同时消除了以前的几个障碍。这种协同作用的结果是基因发现和随后的机制研究的范围和速度都显着增加。这一计划是由下一代测序技术的快速发展,这已经改变了正向遗传学,允许识别ENU诱导的突变表型筛选之前,并通过新的系统生物学方法,允许基因调控和信号网络内的突变的背景。U19计划中的多个核心将支持三个互补项目,这些项目将在几个正交方向上探测免疫系统。UTSW小组将对作为多种NIAID优先病原体组成部分的各种PAMP进行无偏见的免疫反应缺陷筛查。该小组将使用每个家系中存在的突变的知识来加速这些筛选中鉴定的基因的鉴定。ANU小组将选择性地富集殖民地,以筛选系统生物学分析预测在适应性免疫反应中发挥作用的基因突变,并分析这些基因在感染NIAID优先病原体流感和鼠痘病毒期间的作用。西雅图生物医学小组将全面筛选巨噬细胞和树突状细胞对各种先天性免疫激动剂反应的体外缺陷。该小组将重点关注通过外显子组测序鉴定的小鼠,这些小鼠具有ENU诱导的基因突变,这些基因通过系统分析预测为免疫细胞网络的关键调节因子,并将确定这些基因在对NIAID优先病原体沙门氏菌,李斯特菌和流感的免疫应答中的作用。
英文摘要
DESCRIPTION (provided by applicant): The immune response is a double-edged sword; it is absolutely required for host defense, but unregulated, causes inflammatory disease. A number of critical questions regarding the mechanisms that appropriately tailor these pathways remain unanswered. This proposal seeks to uncover novel regulatory mechanisms that control critical aspects of the innate and adaptive response to NIAID priority pathogens. This U19 proposes a novel and fully integrated approach to immunological research that we have termed Systems-Guided Forward Genetics. Here, we combine traditional forward genetics and systems biology methodologies, retaining the advantages of each strategy while eliminating several previous obstacles. The result of this synergy is a significant increase in both the scope and pace of gene discovery and of subsequent mechanistic studies. This program is enabled by the rapid advances in next-generation sequencing technology, which have transformed forward genetics by allowing the identification of ENU-induced mutations prior to phenotypic screening, and by new systems biology approaches that allow contextualization of the mutations within gene regulatory and signaling networks. The multiple Cores within this integrated U19 program will enable and support three complementary Projects that probe the immune system in several orthogonal directions. The UTSW group will conduct an unbiased screen for defective immune responses to a variety of PAMPs that are components of multiple NIAID Priority pathogens. This group will use knowledge of the mutations present in each pedigree to accelerate the identification of genes identified in these screens. The ANU group will selectively enrich the colony of mice to be screened for mutations in genes that have been predicted by systems biology analyses to play a role in adaptive immune responses, and analyze the role of these genes during infection with the NIAID Priority pathogens influenza and ectromelia viruses. The Seattle BioMed group will comprehensively screen macrophages and dendritic cells for in vitro defects in response to a wide-range of innate immune agonists. This group will focus on mice identified by exome sequencing to have ENU induced mutations in genes predicted by systems analysis to be critical regulators of immune ceil networks and will establish the role of these genes in the immune response to the NIAID Priority pathogens Salmonella, Listeria, and influenza.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Systems Approach to Immunity and Inflammation
-
批准号:10242980
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2020
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:10159667
-
项目类别:
-
资助金额:$36.66万
-
财政年份:2020
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:10291571
-
项目类别:
-
资助金额:$188.73万
-
财政年份:2020
-
负责人:Richard J Ulevitch
-
依托单位:
Human Correlation Core
-
批准号:10181123
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2020
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:10189749
-
项目类别:
-
资助金额:$83.86万
-
财政年份:2020
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:8717568
-
项目类别:
-
资助金额:$633.95万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:9767005
-
项目类别:
-
资助金额:$221.33万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Human Correlation Core
-
批准号:10240686
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:9117401
-
项目类别:
-
资助金额:$803.35万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:8523781
-
项目类别:
-
资助金额:$616.69万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Administrative Core
-
批准号:10240684
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:8326361
-
项目类别:
-
资助金额:$635.77万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:10240683
-
项目类别:
-
资助金额:$220.14万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:10395064
-
项目类别:
-
资助金额:$30.29万
-
财政年份:2012
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Immunity and Inflammation
-
批准号:8277180
-
项目类别:
-
资助金额:$1087.94万
-
财政年份:2007
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Innate Immunity-Inflammation-Sepsis
-
批准号:6784636
-
项目类别:
-
资助金额:$538.98万
-
财政年份:2002
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Innate Immunity-Inflammation-Sepsis
-
批准号:6663192
-
项目类别:
-
资助金额:$476.98万
-
财政年份:2002
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Innate Immunity-Inflammation-Sepsis
-
批准号:7107953
-
项目类别:
-
资助金额:$635.94万
-
财政年份:2002
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Innate Immunity-Inflammation-Sepsis
-
批准号:6555146
-
项目类别:
-
资助金额:$482.18万
-
财政年份:2002
-
负责人:Richard J Ulevitch
-
依托单位:
Systems Approach to Innate Immunity-Inflammation-Sepsis
-
批准号:6937206
-
项目类别:
-
资助金额:$661.83万
-
财政年份:2002
-
负责人:Richard J Ulevitch
-
依托单位:
海外基金